{
    "clinical_study": {
        "@rank": "146291", 
        "acronym": "Perseo", 
        "arm_group": {
            "arm_group_label": "Pegasys, injection subcutaneous", 
            "description": "Hepatitis C Virus (HCV) patients monoinfected or coinfected, all genotypes, treatment naive to Peginterferon alfa-2a and Ribavirin (RBV)"
        }, 
        "biospec_descr": {
            "textblock": "Whole blood"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "Primary objective: Evaluate the prevalence of personality disorders in patients starting\n      treatment for hepatitis C in the prison and determine their influence on the evolution of\n      the disease."
        }, 
        "brief_title": "Epidemiological Study to Evaluate Personality Disorders in Prison Populations in Treatment for Hepatitis C", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hepatitis C, Chronic", 
            "Personality Disorders in Prison"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Personality Disorders", 
                "Hepatitis", 
                "Hepatitis A", 
                "Hepatitis C", 
                "Hepatitis C, Chronic"
            ]
        }, 
        "detailed_description": {
            "textblock": "Secondary objectives:\n\n        -  Describe the management of patients with personality disorders on treatment for\n           hepatitis C in the prison.\n\n        -  Describe the characteristics of patients who discontinue the treatment and the reasons\n           for stratifying by the presence of personality disorders."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients 18 years of age.\n\n          -  Patients with expected prison stay beyond the duration of follow-up period of the\n             study.\n\n          -  Patients with chronic HCV infection and detectable viral load to initiate treatment\n             with standard therapy.\n\n          -  Patients their written informed consent to participate in the study.\n\n        Exclusion Criteria:\n\n          -  Patients previously treated with Interferon (IFN) and Ribavirin (RBV).\n\n          -  Patients can not read or understand a written questionnaire at the discretion of the\n             investigator."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "The study population will consist of patients with chronic hepatitis C mono-or co-infected\n        with HIV."
            }
        }, 
        "enrollment": {
            "#text": "263", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01900886", 
            "org_study_id": "GEI-HCC-2010-01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Pegasys, injection subcutaneous", 
                "description": "Treatment as usual clinical practice", 
                "intervention_name": "Peginterferon alfa-2a", 
                "intervention_type": "Other", 
                "other_name": "Pegasys"
            }, 
            {
                "arm_group_label": "Pegasys, injection subcutaneous", 
                "description": "Treatment as usual clinical practice", 
                "intervention_name": "Ribavirin", 
                "intervention_type": "Drug", 
                "other_name": "Copegus"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ribavirin", 
                "Peginterferon alfa-2a", 
                "Interferon-alpha"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "prison, disorder, hepatitis c", 
        "lastchanged_date": "July 12, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Jerez de la Frontera", 
                        "country": "Spain", 
                        "state": "Cadiz", 
                        "zip": "11500"
                    }, 
                    "name": "Centro Penitenciario El Puerto III"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Albolote", 
                        "country": "Spain", 
                        "state": "Granada", 
                        "zip": "18220"
                    }, 
                    "name": "Centro Penitenciario de Albolote"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Las Palmas de Gran Canaria", 
                        "country": "Spain", 
                        "state": "Islas Canarias", 
                        "zip": "35017"
                    }, 
                    "name": "Centro Penitenciario Las Palmas"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santa Cruz de Tenerife", 
                        "country": "Spain", 
                        "state": "Islas Canarias", 
                        "zip": "38290"
                    }, 
                    "name": "Centro Penitenciario de Tenerife"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oca\u00f1a", 
                        "country": "Spain", 
                        "state": "Toledo", 
                        "zip": "45300"
                    }, 
                    "name": "Centro Penitenciario Oca\u00f1a I"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Almeria", 
                        "country": "Spain", 
                        "zip": "04071"
                    }, 
                    "name": "Centro Penitenciario de El Acebuche"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Badajoz", 
                        "country": "Spain", 
                        "zip": "06071"
                    }, 
                    "name": "Centro Penitenciario de Badajoz"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cordoba", 
                        "country": "Spain", 
                        "zip": "14015"
                    }, 
                    "name": "Centro Penitenciario de Cordoba"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jaen", 
                        "country": "Spain", 
                        "zip": "23009"
                    }, 
                    "name": "Centro Penitenciario Jaen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salamanca", 
                        "country": "Spain", 
                        "zip": "37799"
                    }, 
                    "name": "Centro Penitenciario de Topas"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain", 
                        "zip": "41007"
                    }, 
                    "name": "Centro Penitenciario Sevilla I"
                }
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_groups": "1", 
        "official_title": "Prospective Observational Study to Assess Personality Disorders in Prison Populations for Hepatitis C Treatment. \"", 
        "overall_official": {
            "affiliation": "Centro Penitenciario de Hombres de Barcelona. Prisi\u00f3n Modelo", 
            "last_name": "Andres Marco, Medicine", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
                "Spain: Ethics Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Sustained Viral Response (SVR)", 
            "safety_issue": "No", 
            "time_frame": "RNA-VHC at weeks 24 or 48"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01900886"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Grupo de Enfermedades Infecciosas de la Sociedad Espa\u00f1ola de Sanidad Penitenciaria", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Grupo de Enfermedades Infecciosas de la Sociedad Espa\u00f1ola de Sanidad Penitenciaria", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2010", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2010"
    }
}